{"id":"https://openalex.org/W7166563318","doi":"https://doi.org/10.3389/fonc.2026.1917545","title":"PD-L1 deletion or blockade intrinsically reduces macrophage CD80 levels","display_name":"PD-L1 deletion or blockade intrinsically reduces macrophage CD80 levels","publication_year":2026,"publication_date":"2026-10-30","ids":{"openalex":"https://openalex.org/W7166563318","doi":"https://doi.org/10.3389/fonc.2026.1917545","pmid":"https://pubmed.ncbi.nlm.nih.gov/42427499","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13345199"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1917545","doi":"https://doi.org/10.3389/fonc.2026.1917545","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1917545","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1917545/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1917545/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084222624","display_name":"Trinity Q Alaka\u2019i Waddell","orcid":"https://orcid.org/0000-0001-7780-8823","observed_orcids":["https://orcid.org/0000-0001-7780-8823"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trinity Waddell","raw_affiliation_strings":["Department of Biochemistry, University of Utah","Department of Immunology, Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, University of Utah","institution_ids":["https://openalex.org/I223532165"]},{"raw_affiliation_string":"Department of Immunology, Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038413156","display_name":"Haidong Dong","orcid":"https://orcid.org/0000-0002-5782-2983","observed_orcids":["https://orcid.org/0000-0002-5782-2983","https://orcid.org/0000-0001-8543-661X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haidong Dong","raw_affiliation_strings":["Department of Immunology, Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064923815","display_name":"Minna Roh\u2010Johnson","orcid":"https://orcid.org/0000-0003-3961-4547","observed_orcids":["https://orcid.org/0000-0003-3961-4547"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Minna Roh-Johnson","raw_affiliation_strings":["Department of Biochemistry, University of Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, University of Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046758038","display_name":"Jessica Naomi Lancaster","orcid":"https://orcid.org/0000-0003-0398-9988","observed_orcids":["https://orcid.org/0000-0003-0398-9988"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jessica N. Lancaster","raw_affiliation_strings":["Department of Cancer Biology, Mayo Clinic","Department of Immunology, Mayo Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Biology, Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Department of Immunology, Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5046758038","https://openalex.org/A5064923815"],"corresponding_institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I223532165"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.42226357,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6586999893188477,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6586999893188477,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.33180001378059387,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.8640000224113464},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8230000138282776},{"id":"https://openalex.org/keywords/antigen-presentation","display_name":"antigen presentation","score":0.9639999866485596},{"id":"https://openalex.org/keywords/immune-checkpoint-proteins","display_name":"immune checkpoint molecules","score":0.7459999918937683},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cd80","display_name":"CD80","score":0.8740000128746033},{"id":"https://openalex.org/keywords/mhc-class-i","display_name":"MHC class I","score":0.8029999732971191},{"id":"https://openalex.org/keywords/mhc-class-ii","display_name":"MHC class II","score":1.0},{"id":"https://openalex.org/keywords/pd-l2","display_name":"PD-L2","score":0.7770000100135803},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.8220000267028809},{"id":"https://openalex.org/keywords/macrophage-polarization","display_name":"macrophage polarization","score":0.8560000061988831},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.777999997138977},{"id":"https://openalex.org/keywords/bone-marrow-derived-macrophages","display_name":"bone marrow-derived macrophages","score":0.8529999852180481}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.7440999746322632},{"id":"https://openalex.org/C83464605","wikidata":"https://www.wikidata.org/wiki/Q575296","display_name":"Antigen presentation","level":4,"score":0.6492999792098999},{"id":"https://openalex.org/C2776682551","wikidata":"https://www.wikidata.org/wiki/Q21072584","display_name":"Macrophage polarization","level":4,"score":0.6467000246047974},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.6384000182151794},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5738000273704529},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5616000294685364},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.557200014591217},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5148000121116638},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.48989999294281006},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.43380001187324524},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4156999886035919},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40869998931884766},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40790000557899475},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4011000096797943},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.39809998869895935},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.38029998540878296},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.3785000145435333},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.3781999945640564},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.37540000677108765},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.33970001339912415},{"id":"https://openalex.org/C67662055","wikidata":"https://www.wikidata.org/wiki/Q1047791","display_name":"Antigen-presenting cell","level":4,"score":0.3082999885082245},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.28870001435279846},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2872999906539917},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2842999994754791},{"id":"https://openalex.org/C2777702733","wikidata":"https://www.wikidata.org/wiki/Q1356761","display_name":"Immune tolerance","level":3,"score":0.2621000111103058}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fonc.2026.1917545","doi":"https://doi.org/10.3389/fonc.2026.1917545","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1917545","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1917545/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"doi:10.64898/2026.06.23.734016","doi":"https://doi.org/10.64898/2026.06.23.734016","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.06.23.734016","pdf_url":null,"source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmid:42427499","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42427499","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"bioRxiv : the preprint server for biology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13345199","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13345199/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"bioRxiv","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:5e14837860c6489ca301270aa4151f13","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5e14837860c6489ca301270aa4151f13","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1917545","doi":"https://doi.org/10.3389/fonc.2026.1917545","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1917545","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1917545/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000880090","display_name":"The role of lymph node structural organization in na\u00efve T cell decline with age","funder_award_id":"R01AG080037","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7166563318.pdf","grobid_xml":"https://content.openalex.org/works/W7166563318.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1568317937","https://openalex.org/W1982488143","https://openalex.org/W2001717792","https://openalex.org/W2016983859","https://openalex.org/W2050477250","https://openalex.org/W2063264144","https://openalex.org/W2118471749","https://openalex.org/W2125988127","https://openalex.org/W2155464214","https://openalex.org/W2159560463","https://openalex.org/W2160834915","https://openalex.org/W2166478326","https://openalex.org/W2502848651","https://openalex.org/W2615301036","https://openalex.org/W2782998220","https://openalex.org/W2783246934","https://openalex.org/W2883594834","https://openalex.org/W2887577080","https://openalex.org/W2897460617","https://openalex.org/W2898415660","https://openalex.org/W2911604706","https://openalex.org/W2936616584","https://openalex.org/W2980933209","https://openalex.org/W2991095295","https://openalex.org/W3045478644","https://openalex.org/W3092959718","https://openalex.org/W3118522749","https://openalex.org/W3157408691","https://openalex.org/W3179971272","https://openalex.org/W4289783164","https://openalex.org/W4322761553","https://openalex.org/W4389849646","https://openalex.org/W4390064208","https://openalex.org/W4391963061","https://openalex.org/W4392260683","https://openalex.org/W4401729464","https://openalex.org/W4406947462","https://openalex.org/W4408683246","https://openalex.org/W4414106226","https://openalex.org/W4414299229","https://openalex.org/W4415611948","https://openalex.org/W4417107012"],"related_works":["https://openalex.org/W2883594834","https://openalex.org/W7201863358","https://openalex.org/W4385686477","https://openalex.org/W2911604706","https://openalex.org/W3136706811","https://openalex.org/W2055480694","https://openalex.org/W2548728296","https://openalex.org/W2984395743","https://openalex.org/W3205986048","https://openalex.org/W4313368637"],"abstract_inverted_index":{"Macrophages":[0,87],"in":[1,21,100,120,147,184,192,196,219,222],"the":[2,19,43,48,53,113,131,160,223],"tumor":[3,49,95,224],"microenvironment":[4],"are":[5],"known":[6],"to":[7,179],"upregulate":[8],"PD-L1":[9,23,77,173,194],"expression,":[10],"thereby":[11],"suppressing":[12],"T":[13,140],"cells":[14],"through":[15],"PD-1":[16],"ligation.":[17],"However,":[18],"manner":[20],"which":[22,148,193],"expression":[24,114],"intrinsically":[25],"impacts":[26],"macrophages":[27,72,197],"and":[28,63,79,94,143,156,167,175,210,214],"their":[29],"immunomodulatory":[30],"phenotype":[31],"is":[32],"less":[33],"clear.":[34],"Clarifying":[35],"this":[36],"knowledge":[37],"gap":[38],"would":[39],"yield":[40],"insight":[41],"into":[42],"mechanisms":[44],"of":[45,57,115,130,139,153,163],"immunosuppression":[46],"within":[47],"microenvironment.":[50,225],"To":[51],"characterize":[52],"macrophage":[54,116,180],"intrinsic":[55],"role":[56,201,218],"PD-L1,":[58],"we":[59,149],"used":[60],"complementary":[61],"genetic":[62,76,106,154],"pharmacological":[64],"approaches":[65],"by":[66],"analyzing":[67],"primary":[68],"murine":[69],"bone":[70],"marrow-derived":[71],"(BMDMs)":[73],"with":[74,83],"complete":[75],"deletion":[78,107,155,174],"wildtype":[80],"BMDMs":[81],"treated":[82],"anti-PD-L1":[84],"blocking":[85],"antibodies.":[86],"were":[88],"evaluated":[89],"across":[90],"na\u00efve,":[91],"pro-inflammatory":[92],"(M1),":[93],"conditioned":[96],"(TCM)":[97],"polarization":[98,117],"states":[99],"vitro.":[101],"Unlike":[102],"prior":[103],"reports,":[104],"neither":[105],"nor":[108],"antibody":[109,157],"blockade":[110,158,177],"dramatically":[111],"altered":[112],"markers":[118],"or":[119],"vitro":[121],"phagocytic":[122],"capacity.":[123],"Both":[124],"conditions":[125],"consistently":[126],"reduced":[127],"surface":[128,161],"levels":[129,162,213],"M1-associated":[132],"costimulatory":[133],"molecule":[134,212],"CD80,":[135],"prompting":[136],"further":[137],"analysis":[138],"cell":[141],"interacting":[142],"antigen":[144,208],"presenting":[145],"proteins,":[146],"revealed":[150],"disparate":[151],"effects":[152],"on":[159],"MHCI,":[164],"MHCII,":[165],"PD-1,":[166,206],"PD-L2.":[168],"These":[169],"findings":[170],"suggest":[171],"that":[172],"antibody-mediated":[176],"contribute":[178],"immune":[181,220],"regulatory":[182],"profiles":[183],"distinct":[185],"manners.":[186],"This":[187],"difference":[188],"supports":[189],"a":[190,203,216],"model":[191],"functions":[195],"beyond":[198],"its":[199],"canonical":[200],"as":[202],"ligand":[204],"for":[205],"influencing":[207],"presentation":[209],"checkpoint":[211],"playing":[215],"broader":[217],"regulation":[221]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-06-30T00:00:00"}